Miragen Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.1M | 143k | 21.78 |
| 2023-09-30 | $1.1M | 68k | 15.36 |
| 2023-06-30 | $1.9M | 80k | 23.80 |
| 2023-03-31 | $1.8M | 69k | 25.44 |
| 2022-12-31 | $4.3M | 146k | 29.21 |
| 2022-09-30 | $1.0M | 49k | 20.55 |
| 2022-06-30 | $0 | 13 | 0.00 |
| 2022-03-31 | $0 | 222 | 0.00 |
| 2021-12-31 | $0 | 13 | 0.00 |
| 2021-09-30 | $0 | 1.4k | 0.00 |
| 2021-06-30 | $0 | 13 | 0.00 |
| 2021-03-31 | $0 | 13 | 0.00 |